---
title: Prof Yiu Kai Hang
permalink: /prof-yiu-kai-hang/
variant: tiptap
description: ""
image: /images/ASPIRE Network /Yiu_Kai_Hang.jpg
---
<p></p>
<div class="isomer-image-wrapper">
<img style="width: 30%;" height="auto" width="100%" alt="" src="/images/ASPIRE Network /Yiu_Kai_Hang.jpg">
</div>
<h4><strong>Prof Yiu Kai Hang</strong></h4>
<p>Professor Yiu is a distinguished clinical cardiologist specializing in
advanced cardiovascular therapeutics, with a focus on interventional procedures
such as percutaneous coronary intervention for coronary artery disease
and structural intervention for valvular disease. His research interests
lie in Advanced Cardiovascular Imaging and Big Data Analytics, enabling
the identification of subclinical cardiovascular abnormalities to enhance
patient management and improve outcomes.</p>
<p>Professor Yiu has spearheaded significant research projects including
the Chinese Valvular Heart Disease Study (CVATS), the Chinese Diabetic
Heart Disease Study (CDATS), and the Chinese Rheumatology Heart Disease
Study (CRADS). Leveraging big data analytics, he evaluates epidemiology
in common cardiovascular diseases, drug safety, and efficacy. He also explores
the use of angiographic-guided functional assessment to enhance success
rates following coronary artery interventions. He has articles published
as the corresponding author in the top three cardiology journals: Circulation,
European Heart Journal, and Journal of the American College of Cardiology.</p>
<p>At the HKU-Shenzhen Hospital, a pioneering institution established in
2012 by the faculty, Professor Yiu leads the Division of Cardiology. His
outstanding contributions have been recognized with numerous national and
international accolades, such as the Australian Council on Healthcare Standards
Global Safety Award in 2021. The Division of Cardiology was designated
as a Key Development Specialty by the Shenzhen Municipal Health Commission
in 2020. In 2018, Professor Yiu was honored as an Elite Young Medical Leader
of Guangdong Province, China, and designated as a B-grade talent in the
Shenzhen Health System. He was also the recipient of the Clinical Service
Excellence Award by the Faculty in 2023, underscoring his clinical expertise
and service advancements.</p>